Innocan Pharma Corp.
Sector and Industry
Consumer Non-Cyclicals, Household Products
Performance (1Y)
67.95%
Market Cap
-
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
-0.22 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Procter & Gamble Co | 317.85 Bil. | 77.53 Bil. | 24.48 | +6.80 % | 0.00 | - |
| L'Oreal S.A. | 195.68 Bil. | 44.05 Bil. | 31.93 | -4.39 % | 0.00 | - |
| Unilever PLC | 121.38 Bil. | 50.55 Bil. | 20.33 | -1.01 % | 0.00 | - |
| Midea Group Co. Ltd. 'H' | 70.60 Bil. | 56.38 Bil. | 13.51 | +9.42 % | 0.00 | - |
| Colgate-Palmolive Co | 53.91 Bil. | 18.07 Bil. | 30.06 | -29.24 % | 0.00 | - |
| Reckitt Benckiser Group PLC | 46.22 Bil. | 16.60 Bil. | 12.82 | +121.23 % | 0.00 | - |
| Kimberly-Clark Corp | 28.51 Bil. | 14.58 Bil. | 16.63 | -38.93 % | 0.00 | - |
| Kenvue Inc. | 28.05 Bil. | 13.41 Bil. | 22.50 | +36.84 % | 0.00 | - |
| Estee Lauder Companies Inc | 24.76 Bil. | 13.14 Bil. | - | -389.00 % | 0.00 | - |
| Beiersdorf AG | 20.47 Bil. | 9.85 Bil. | 22.05 | +2.96 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 1.975 G | 0 Units |
| PRICE DETERMINATION TIME | 06/05/2026 / 09:56:26 PM | |
| DAILY VOLUME (UNITS) | 500 | |
| DAILY HIGH / LOW | 2.02 | 1.97 |
| PREV. DAY'S PRICE | 2.02 | (06/04) |
| CHANGE DAY BEFORE | -0.04 | -2.23 % |
| 52 WEEK HIGH / LOW | 496.4375 (09/04) | 1.875 (05/26) |
Key Figures (in EUR)
| 2027 | 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | - | - | -0.22 | -0.39 | -1.10 |
| DIVIDENDS PER SHARE | - | - | 0.00 | 0.00 | 0.00 |
| DIVIDEND YIELD IN % | - | - | 0.00 % | 0.00 % | 0.00 % |
| DIVIDEND GROWTH IN % | - | - | - | - | - |
| PRICE - EARNINGS RATIO | - | - | - | - | - |
| PRICE - BOOK RATIO | - | - | 3.93 | 8.20 | 15.36 |
| PRICE - SALES RATIO | - | - | 0.81 | 1.46 | 4.32 |
| PRICE - CASH FLOW RATIO | - | - | 43.37 | - | - |
Master Data
| WKN | A41FTP |
| ISIN | CA45783P5085 |
| SYMBOL | IP40 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | INNOCAN PHARMA CORP. |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Consumer Non-Cyclicals, Household Products |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -12.61 % | -41.91 % | -48.30 % | -65.65 % | -67.95 % | -82.36 % | -91.05 % | -49.36 % |
| HIGH | 2.29 | 3.59 | 4.42 | 6.25 | 496.44 | 496.44 | 496.44 | 6.25 |
| LOW | 1.97 | 1.88 | 1.88 | 1.88 | 1.88 | 1.88 | 1.88 | 1.88 |
Dividend
per share
INNOCAN PHARMA CORP. does not deliver dividend information
Company profile
InnoCan Pharma Corp. operates as a pharmaceutical tech company. It operates through the Online Sales and Other Operations segments. The Online Sales segment engages in the development of non-CBD personal care and beauty products in the United States for online platforms such as Amazon, and other e-commerce retail sales. The Other Operations segment involves in the development of several drug delivery platforms, combining cannabinoids with other pharmaceutical ingredients as well as the development and sale of CBD-integrated topical products. The company was founded by Iris Bincovich and Nir Avram in October 2017 and is headquartered in Alberta, Canada.
Structured products for Innocan Pharma Corp.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.